Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Akihide Masumoto"'
Autor:
Akifumi Kuwano, Masayoshi Yada, Kazuki Kurosaka, Kosuke Tanaka, Akihide Masumoto, Kenta Motomura
Publikováno v:
JGH Open, Vol 7, Iss 2, Pp 98-104 (2023)
Abstract Background and Aim Direct‐acting antivirals (DAAs) have recently been developed to treat hepatitis C virus (HCV) infection. Additionally, interferon‐free DAA treatment has improved liver function and reduced the risk of hepatocellular ca
Externí odkaz:
https://doaj.org/article/04fbf6e554fa41ce866926d5ac88c275
Autor:
AKIFUMI KUWANO, SHIGEHIRO NAGASAWA, YUTA KOGA, KOSUKE TANAKA, MASAYOSHI YADA, AKIHIDE MASUMOTO, KENTA MOTOMURA
Publikováno v:
Experimental & Therapeutic Medicine; Sep2024, Vol. 28 Issue 3, p1-7, 7p
Autor:
AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO, KENTA MOTOMURA
Publikováno v:
In Vivo; Jul/Aug2024, Vol. 38 Issue 4, p1854-1858, 5p
Autor:
AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO, KENTA MOTOMURA
Publikováno v:
Cancer Diagnosis & Prognosis; Mar/Apr2024, Vol. 4 Issue 2, p111-116, 6p
Autor:
Akifumi Kuwano, Masayoshi Yada, Kazuki Kurosaka, Kosuke Tanaka, Akihide Masumoto, Kenta Motomura
Publikováno v:
JGH Open. 7:98-104
Autor:
AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO, KENTA MOTOMURA
Publikováno v:
Cancer Diagnosis & Prognosis; Jan/Feb2024, Vol. 4 Issue 1, p34-41, 8p
Autor:
Akifumi Kuwano, Kosuke Tanaka, Shigehiro Nagasawa, Yusuke Morita, Masayoshi Yada, Akihide Masumoto, Kenta Motomura
Publikováno v:
Kanzo. 63:335-341
Autor:
Akifumi Kuwano, Masayoshi Yada, Yoshiko Miyazaki, Kosuke Tanaka, Kazuki Kurosaka, Yoshihiro Ohishi, Akihide Masumoto, Kenta Motomura
Publikováno v:
Oncology Letters. 25
Autor:
SHIGEHIRO NAGASAWA, AKIFUMI KUWANO, KOSUKE TANAKA, MASAYOSHI YADA, AKIHIDE MASUMOTO, KENTA MOTOMURA
Publikováno v:
Cancer Diagnosis & Prognosis; Nov/Dec2023, Vol. 3 Issue 6, p660-666, 7p
Autor:
Kenta Motomura, Yusuke Morita, Shigehiro Nagasawa, Kosuke Tanaka, Akihide Masumoto, Masayoshi Yada, Akifumi Kuwano
Publikováno v:
Journal of Viral Hepatitis. 29:35-42
Direct-acting antivirals (DAAs) have recently been developed to treat hepatitis C virus (HCV) infection, and interferon-free DAA treatment has improved liver function of HCV patients. The risk of hepatocellular carcinoma (HCC) occurrence following HC